Public Relations Representative
Fromson joined Michigan Medicine in March 2021. He covers the neurosciences and cardiovascular medicine. He spent three years as a television reporter in West Michigan and is passionate about multimedia storytelling. Contact: [email protected] Twitter: @noahfromson
Health Lab
A new study finds AI-based diagnostic screening system, DeepGlioma, detects genetic mutations in brain tumors in under 90 seconds. Streamlining glioma diagnosis and treatment.
Health Lab
New multiple sclerosis research finds insomnia, sleep apnea contribute to reports of cognitive decline in women.
Health Lab
For an abdominal aortic aneurysm, female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study finds.
Health Lab
RNA modification ‘pivotal’ for protein linked to neurodegeneration in ALS.
Health Lab
A Michigan Medicine neurologist explains more about frontotemporal dementia.
Health Lab
For peripheral arterial disease, a patient and physician stress the importance of a strong partnership to guide treatment.
Health Lab
For chest pain, a cardiologist from University of Michigan Health discusses other potential causes of the symptom.
Health Lab
Metabolic mechanism protects hearts from damaging metabolites that build up in cold storage, study finds
Health Lab
ALS didn’t keep a man from his lifelong passion for producing music
Health Lab
Using stroke as a measure of quality after TAVR could put stroke centers at a disadvantage, the study suggests
Health Lab
The spinal nerve procedure has been shown to provide an effective decrease in muscle spasticity long term.
Health Lab
The findings may support the immune pathway as a bridge between diet and neurologic disease
Health Lab
A neuromuscular specialist shares helpful facts about symptoms, diagnosis and treatment.
Health Lab
Myocarditis related to immune checkpoint inhibitors always co-occurs with damage to skeletal muscle, the study finds.
Health Lab
A study led by Michigan Medicine has uncovered that suPAR, a protein, causes atherosclerosis, linking cardiovascular disease and kidney disease. The research shows potential for suPAR to be a treatment target for both conditions.